RS

Ratnaprabha Sunil Patil

Active Director Director DIN 10743154
DIN 10743154 First appointment Aug 2024 Primary industry Paper
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2024
Shareholding value •••• Premium profile

About Ratnaprabha Sunil Patil

Data last updated:

Ratnaprabha Sunil Patil is a Director at Shamrax Pharmaceuticals Private Limited (since 2024). The company operates in Paper. Shamrax Pharmaceuticals Private Limited reported revenue of ₹13.5 Lakh (FY 2025).

DIN 10743154
Primary Designation Director
Industry Paper
First Appointment 14 Aug 2024
Oldest Company Age 2 yrs
Largest company Shamrax Pharmaceuticals Private Limited · ₹13.5 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director14 Aug 20242024₹13.5 Lakh (FY 2025)Active

Board colleagues of Ratnaprabha Sunil Patil

Directorship timeline

Open interactive timeline →
Shamrax Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Ratnaprabha Sunil Patil

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ratnaprabha Sunil Patil

Ratnaprabha Sunil Patil currently holds 1 directorship: Shamrax Pharmaceuticals Private Limited (Director, since 14 Aug 2024, revenue ₹13.5 Lakh (FY 2025)).

Ratnaprabha Sunil Patil was first appointed on 14 Aug 2024 as Director at Shamrax Pharmaceuticals Private Limited.

The current boards of Ratnaprabha Sunil Patil's companies include Shyamal Pandurang Jamdar (Shamrax Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available